Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol 10:81–89. https://doi.org/10.1177/106689690201000201
Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 23:70–83. https://doi.org/10.1053/j.semdp.2006.09.001
Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39:1411–1419. https://doi.org/10.1016/j.humpath.2008.06.025
Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P (2011) Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 13:265–274. https://doi.org/10.1016/S1470-2045(11)70299-6
Rossi S, Miceli R, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Sidoni A, Toffolatti L, Laurino L, Mariani L, Vinaccia V, Gnocchi C, Gronchi A, Casali PG, Dei Tos AP (2011) Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. Am J Surg Pathol 35:1646–1656. https://doi.org/10.1097/PAS.0b013e31822d63a7
Gold JS, Gönen M, Gutiérrez A, Broto JM, García-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF, Antonescu CR, Donohue JH, DeMatteo RP (2009) Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol 10:1045–1052. https://doi.org/10.1016/S1470-2045(09)70242-6
Article PubMed PubMed Central Google Scholar
Gal R, Rath-Wolfson L, Rosenblatt Y, Halpern M, Schwartz A, Koren R (2005) An improved technique for mitosis counting. Int J Surg Pathol 13:161–165. https://doi.org/10.1177/106689690501300206
Meuten DJ, Moore FM, George JW (2016) Mitotic count and the field of view area: time to standardize. Vet Pathol 53:7–9. https://doi.org/10.1177/0300985815593349
Article CAS PubMed Google Scholar
Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dufresne A, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F, Grignani G, Haas R, Hassan AB, Hindi N, Hohenberger P, Joensuu H, Jones RL, Jungels C, Jutte P, Kasper B, Kawai A, Kopeckova K, Krákorová DA, Le Cesne A, Le Grange F, Legius E, Leithner A, Lopez-Pousa A, Martin-Broto J, Merimsky O, Messiou C, Miah AB, Mir O, Montemurro M, Morosi C, Palmerini E, Pantaleo MA, Piana R, Piperno-Neumann S, Reichardt P, Rutkowski P, Safwat AA, Sangalli C, Sbaraglia M, Scheipl S, Schöffski P, Sleijfer S, Strauss D, Strauss SJ, Hall KS, Trama A, Unk M, van de Sande MAJ, van der Graaf WTA, van Houdt WJ, Frebourg T, Gronchi A, Stacchiotti S (2022) Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 33:20–33. https://doi.org/10.1016/j.annonc.2021.09.005
Article CAS PubMed Google Scholar
Poveda A, García Del Muro X, López-Guerrero JA, Cubedo R, Martínez V, Romero I, Serrano C, Valverde C, Martín-Broto J, GEIS (GrupoEspañol de Investigaciónen Sarcomas/Spanish Group for Sarcoma Research) (2017) GEIS guidelines for gastrointestinal sarcomas (GIST). Cancer Treat Rev 55:107–119. https://doi.org/10.1016/j.ctrv.2016.11.011
Brierley JD, Gospodarowicz MK, Wittekind C (2017) UICC - TNM classification of malignant tumors, 8th edn. Wiley Blackwell, New Jersey, pp 124–126
Koo DH, Ryu MH, Kim KM, Yang HK, Sawaki A, Hirota S, Zheng J, Zhang B, Tzen CY, Yeh CN, Nishida T, Shen L, Chen LT, Kang YK (2016) Asian Consensus Guidelines for the diagnosis and management of gastrointestinal stromal tumor. Cancer Res Treat 48:1155–1166. https://doi.org/10.4143/crt.2016.187
Article PubMed PubMed Central Google Scholar
Landi B, Blay JY, Bonvalot S, Brasseur M, Coindre JM, Emile JF, Hautefeuille V, Honore C, Lartigau E, Mantion G, Pracht M, Le Cesne A, Ducreux M, Bouche O, «Thésaurus National de Cancérologie Digestive (TNCD)» (Fédération Francophone de Cancérologie Digestive (FFCD), FédérationNationale de Centres de LutteContre les Cancers (UNICANCER), GroupeCoopérateurMultidisciplinaireenOncologie (GERCOR), SociétéFrançaise de Chirurgie Digestive (SFCD), SociétéFrançaise de RadiothérapieOncologique (SFRO), SociétéFrançaised’Endoscopie Digestive (SFED), SociétéNationaleFrançaise de Gastroentérologie (SNFGE) (2019) Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis 51:1223–1231. https://doi.org/10.1016/j.dld.2019.07.006
Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29:52–68. https://doi.org/10.1097/01.pas.0000146010.92933.de
Miettinen M, Makhlouf H, Sobin LH, Lasota J (2006) Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 30:477–489. https://doi.org/10.1097/00000478-200604000-00008
Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130:1466–1478. https://doi.org/10.5858/2006-130-1466-GSTROM
Article CAS PubMed Google Scholar
Nishida T, Sato S, Ozaka M, Nakahara Y, Komatsu Y, Kondo M, Cho H, Hirota S, Kagimura T, Kurokawa Y, Kitagawa Y, STAR ReGISTry Investigators (2022) Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world. Gastric Cancer 25:956–965. https://doi.org/10.1007/s10120-022-01310-z
留言 (0)